http://www.medscape.com/viewprogram/3297?src=search

Are All Atypical Antipsychotics Equal for the Treatment of Cognition and
Affect in Schizophrenia? CME
Chairperson: Stephen M. Stahl, MD, PhD; Faculty: Herbert Y. Meltzer, MD;
Jonathan M. Meyer, MD; Lili C. Kopala, MD, FRCPC
Disclosures <http://www.medscape.com/viewprogram/3297_authors>


This activity is based on transcripts and slides of presentations as
delivered by the faculty at the "Are All Atypical Antipsychotics Equal
for the Treatment of Cognition and Affect in Schizophrenia?" symposium
held at the Hilton New York in New York, New York, on May 2, 2004. This
program is based on an Industry-Supported Symposium presented at the
American Psychiatric Association 2004 Annual Meeting.



<http://www.medscape.com/viewprogram/3297?src=search>


[Non-text portions of this message have been removed]